2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.

Details for Australian Patent Application No. 2007248950 (hide)

Owner AstraZeneca AB

Inventors Lepisto, Matti; Lawitz, Karolina; Lonn, Hans; Ray, Asim; Hansen, Peter

Agent Freehills

Pub. Number AU-B-2007248950

PCT Pub. Number WO2007/129962

Priority 60/798,786 08.05.06 US

Filing date 7 May 2007

Wipo publication date 15 November 2007

Acceptance publication date 18 November 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/129962 Priority application(s): WO2007/129962

18 November 2010 Application Accepted

  Published as AU-B-2007248950

17 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007248951-2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.

2007248949-Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation